850 related articles for article (PubMed ID: 25869441)
21. [Mechanisms and medical implications of replicative senescence].
Ksiazek K; Trómińska-Starczyńska J; Witowski J
Pol Arch Med Wewn; 2005 Sep; 114(3):918-23. PubMed ID: 16708569
[TBL] [Abstract][Full Text] [Related]
22. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.
McGregor F; Muntoni A; Fleming J; Brown J; Felix DH; MacDonald DG; Parkinson EK; Harrison PR
Cancer Res; 2002 Aug; 62(16):4757-66. PubMed ID: 12183435
[TBL] [Abstract][Full Text] [Related]
23. Activation of p53/p21waf1 pathway is associated with senescence during v-Ha-ras transformation of immortal C2C12 myoblasts.
D'Orazi G; Soddu S; Sacchi A
Anticancer Res; 2000; 20(5B):3497-502. PubMed ID: 11131653
[TBL] [Abstract][Full Text] [Related]
24. [Senescence: a telomeric limit to immortality or a cellular response to physiologic stresses?].
Gire V
Med Sci (Paris); 2005 May; 21(5):491-7. PubMed ID: 15885198
[TBL] [Abstract][Full Text] [Related]
25. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
26. Aging with ING: a comparative study of different forms of stress induced premature senescence.
Rajarajacholan UK; Riabowol K
Oncotarget; 2015 Oct; 6(33):34118-27. PubMed ID: 26439691
[TBL] [Abstract][Full Text] [Related]
27. Pharmacologic p53 activation blocks cell cycle progression but fails to induce senescence in epithelial cancer cells.
Huang B; Deo D; Xia M; Vassilev LT
Mol Cancer Res; 2009 Sep; 7(9):1497-509. PubMed ID: 19737973
[TBL] [Abstract][Full Text] [Related]
28. Expression of human telomerase reverse transcriptase mediates the senescence of mesenchymal stem cells through the PI3K/AKT signaling pathway.
Zhao Q; Wang XY; Yu XX; Zhai YX; He X; Wu S; Shi YA
Int J Mol Med; 2015 Sep; 36(3):857-64. PubMed ID: 26178664
[TBL] [Abstract][Full Text] [Related]
29. Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase.
Vaziri H; Benchimol S
Oncogene; 1999 Dec; 18(53):7676-80. PubMed ID: 10618707
[TBL] [Abstract][Full Text] [Related]
30. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
Babizhayev MA; Yegorov YE
J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
[TBL] [Abstract][Full Text] [Related]
31. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition.
Xu HJ; Zhou Y; Ji W; Perng GS; Kruzelock R; Kong CT; Bast RC; Mills GB; Li J; Hu SX
Oncogene; 1997 Nov; 15(21):2589-96. PubMed ID: 9399646
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
[TBL] [Abstract][Full Text] [Related]
33. Senescence and immortalization: role of telomeres and telomerase.
Shay JW; Wright WE
Carcinogenesis; 2005 May; 26(5):867-74. PubMed ID: 15471900
[TBL] [Abstract][Full Text] [Related]
34. Tumor viruses and replicative immortality--avoiding the telomere hurdle.
Chen X; Kamranvar SA; Masucci MG
Semin Cancer Biol; 2014 Jun; 26():43-51. PubMed ID: 24486644
[TBL] [Abstract][Full Text] [Related]
35. On the road to immortality: hTERT upregulation in cancer cells.
Janknecht R
FEBS Lett; 2004 Apr; 564(1-2):9-13. PubMed ID: 15094035
[TBL] [Abstract][Full Text] [Related]
36. α-Catulin knockdown induces senescence in cancer cells.
Fan LC; Chiang WF; Liang CH; Tsai YT; Wong TY; Chen KC; Hong TM; Chen YL
Oncogene; 2011 Jun; 30(23):2610-21. PubMed ID: 21278790
[TBL] [Abstract][Full Text] [Related]
37. What has senescence got to do with cancer?
Dimri GP
Cancer Cell; 2005 Jun; 7(6):505-12. PubMed ID: 15950900
[TBL] [Abstract][Full Text] [Related]
38. Escape from premature senescence is not sufficient for oncogenic transformation by Ras.
Peeper DS; Dannenberg JH; Douma S; te Riele H; Bernards R
Nat Cell Biol; 2001 Feb; 3(2):198-203. PubMed ID: 11175753
[TBL] [Abstract][Full Text] [Related]
39. Identification of senescence-associated genes and their networks under oxidative stress by the analysis of Bach1.
Ota K; Dohi Y; Brydun A; Nakanome A; Ito S; Igarashi K
Antioxid Redox Signal; 2011 Jun; 14(12):2441-51. PubMed ID: 21110788
[TBL] [Abstract][Full Text] [Related]
40. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
